SEC Tracker
Get the app

Lantern Pharma LTRN

Lantern Pharma Inc. received notice from The Nasdaq Stock Market LLC

Form
8-K
Filed
Importance
Routine
  • Reports an exchange listing deficiency notice (3.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Lantern Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Rein Therapeutics RNTX public float $32M, Jun 30, 2025
  2. Abvc Biopharma ABVC public float $37M, Jun 30, 2025
  3. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  4. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025
  5. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025